Ubs Group Ag Novavax Inc Put Options Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$3.89 - $20.97 $142,763 - $769,599	36,700 New	36,700 $464,000
Q4 2022 Feb 08, 2023	BUY	$8.86 - $25.04 $5,316 - $15,024	600 New	600 $6,000
Q2 2022 Aug 10, 2022	SELL	$36.28 - $75.29 $362,800 - $752,900	-10,000 Reduced 25.64%	29,000 $1.49 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $2.68 Million - $5.5 Million	-38,500 Reduced 49.68%	39,000 $2.87 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $6.39 Million - $10.4 Million	47,500 Added 158.33%	77,500 $11.1 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $3.63 Million - $7.73 Million	30,000 New	30,000 $6.37 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.